3778-25-4

Usage

Uses

Used in Pharmaceutical Industry:
7''-O-Methylsciadopitysin is used as a potential therapeutic agent for its antioxidant properties, which may help in reducing oxidative stress and inhibiting lipid peroxidation in cells. This makes it a candidate for the development of treatments targeting various health conditions.
Used in Cardiovascular Health Applications:
In the field of cardiovascular health, 7''-O-Methylsciadopitysin is used as a potential remedy for cardiovascular disorders due to its ability to reduce oxidative stress, which is a contributing factor to such conditions.
Used in Oncology Research:
7''-O-Methylsciadopitysin is used as a subject of research in oncology for its potential as a natural remedy in cancer treatment. Its antioxidant properties and effects on reducing oxidative stress may contribute to its potential use in managing or treating cancer.
Used in Nutraceutical Development:
7''-O-Methylsciadopitysin is used as an ingredient in the development of nutraceuticals, where its antioxidant properties could be leveraged to support overall health and well-being.

Upstream product

• 186581-53-3 diazomethane 
• 22136-74-9 podocarpusflavone A 
• 481-45-8 amentoflavone 4',7'',4'''-trimethyl ether 
• 1617-53-4 amentoflavone 
• 77-78-1 dimethyl sulfate 
• 548-19-6 isoginkgetin 
• 74-88-4 methyl iodide 
• 3778-26-5 Amentoflavon 

Downstream Products

• 22783-09-1 5,5'-diacetoxy-7,7'-dimethoxy-2'-(4-methoxy-phenyl)-2,8'-(4-methoxy-m-phenylene)-bis-chromen-4-one 

Relevant academic research and scientific papers

COMPOUNDS, COMPOSITION AND USES THEREOF FOR TREATING CANCER

The present invention relates to the fields of medicine and cancer treatment. The invention more specifically relates to new compounds which are typically for use as a medicament. In particular, the invention relates to the use of these new compounds for increasing the presentation, typically the production and presentation, of Pioneer Translation Products (PTPs)-derived antigens by cancer cells in a subject, and inducing or stimulating an immune response in the subject. The present disclosure also relates to uses of such compounds, in particular to prepare a pharmaceutical composition and/or to allow or improve the efficiency of a cancer therapy in a subject in need thereof. The invention also discloses methods for preventing or treating cancer, cancer metastasis and/or cancer recurrence in a subject. The present invention in addition provides kits suitable for preparing a composition according to the present invention and/or for implementing the herein described methods.

13C NMR STUDIES OF SOME NATURALLY OCCURRING AMENTOFLAVONE AND HINOKIFLAVONE BIFLAVONOIDS

The 13C NMR spectra of a range of amentoflavone and honokiflavone biflavonoids are reported, most for the first time.Substituent shifts relating to the interflavonoid linkages and to specific methylation patterns are defined and appear to be of diagnostic value.Key Word Index - 13C NMR; amentoflavones; hinokiflavones; methyl ethers; dihydro-derivatives.

TERPENOID AND BIFLAVONOID CONSTITUENTS OF CALOPHYLLUM CALABA AND GARCINIA SPICATA FROM SRI LANKA

A new bark acid, isochapelieric acid (cis-chapelieric acid), chapelieric acid, friedelin, friedelan-3β-ol, canophyllal, canophyllol, friedelan-3β,28-diol, canophyllic acid and amentoflavone have been isolated and characterized from leaf extractives of Cal

BIFLAVANOIDS, NORDITERPENES AND A NORTRITERPNE FROM PODOCARPUS URBANII

Key Word Index - Podocarpus urbanii; Podocarpaceae; biflavanoid; urbalactone, a new norditerpene: 2,3-dihydropodolide; podolide; nagilactone C; norditerpene, C27H44O6. The structures of a biflavanoid, two new norditerpenes, urbanolactone and 2,3-dihydropodolide, an ecdysterol, as well as a known biflavanoid, nagilactone C and podolide from Podocarpus urbanii were elucidated.